# FEAT-004: Content Extraction & Mapping

**Purpose:** Map existing content to new 11-section structure and identify gaps

---

## ğŸ“¦ SECTION 1: HERO
**Target Title:** "Building the Safety OSâ„¢ for the $1 Trillion Humanoid Healthcare Market"

### **Existing Content to Reuse:**
- âœ… Video embed (YouTube WwxU1KrYACk) - currently in Humanoid Healthcare section
- âœ… "$1 Trillion" messaging - currently in multiple places
- âœ… "Safety OS" branding - established throughout site

### **New Content Needed:**
- ğŸ†• Investor-focused headline (not "Empowering Patients & Transforming Healthcare")
- ğŸ†• Sub-headline emphasizing regulatory moat
- ğŸ†• Brief value proposition (1-2 sentences max)

### **Proposed Copy:**
**H1:** "Building the Safety OSâ„¢ for the $1 Trillion Humanoid Healthcare Market"  
**Sub-headline:** "The first regulatory-grade software platform that makes humanoid robots safe, compliant, and commercially viable for patient care."  
**CTA:** "Watch Our Investor Pitch" (links to embedded video below)

---

## ğŸ“¦ SECTION 2: URGENCY
**Target Title:** "A Global Crisis Meets a Market Inflection Point"

### **Existing Content to Reuse:**
- âœ… "Global caregiver crisis" - mentioned in Mission & Technology
- âœ… "1.6B over 65" - need to verify this stat or use from blueprint

### **New Content Needed:**
- ğŸ†• Urgency framing (crisis + opportunity)
- ğŸ†• Market timing narrative
- ğŸ†• Demographic statistics

### **Proposed Copy:**
**H2:** "A Global Crisis Meets a Market Inflection Point"

**Content:**
"The world faces an unprecedented caregiver crisis. By 2030, **1.6 billion people over 65** will need daily care, but there aren't enough human caregivers to meet demand. Healthcare systems are collapsing under the weight of chronic staffing shortages, burnout, and rising costs.

Meanwhile, **affordable humanoid robots** from companies like Unitree and Boston Dynamics are entering the market at **$16,000-$30,000**â€”finally making robotic caregivers economically viable for hospitals, nursing homes, and home care.

But there's a critical problem: **No one has solved the safety and regulatory challenge.**"

---

## ğŸ“¦ SECTION 3: RISK
**Target Title:** "Affordable Home Robots Are About to Be Misused"

### **Existing Content to Reuse:**
- âœ… "Liability risk" mentioned in Mission & Technology
- âœ… "Unacceptable liability risks" in AIITL description

### **New Content Needed:**
- ğŸ†• "Ticking time bomb" narrative
- ğŸ†• 4 specific risk points (from blueprint)

### **Proposed Copy:**
**H2:** "Affordable Home Robots Are About to Be Misused"

**Content:**
"Without regulatory-grade safety controls, the humanoid healthcare market faces a **ticking liability time bomb**:

1. **Patient Safety Risk:** Autonomous robots making critical care decisions without physician oversight could harm vulnerable patients
2. **Regulatory Non-Compliance:** Off-label use of general-purpose robots for medical tasks violates FDA regulations
3. **Liability Exposure:** Hospitals and care facilities face massive lawsuits if robots cause patient harm
4. **Market Paralysis:** Without clear compliance pathways, institutional buyers won't adoptâ€”stalling the entire $1T market

**The industry needs a regulatory bridge. That's where we come in.**"

---

## ğŸ“¦ SECTION 4: SOLUTION
**Target Title:** "We Build the Regulatory-Grade Software 'Brain' (SaMD plug-in)"

### **Existing Content to Reuse:**
- âœ… "Safety OS" branding
- âœ… "Physician-in-the-Loop (AIITL) framework" - from Mission & Technology
- âœ… "Hardware-agnostic" - implied in current content
- âœ… "SaMD" positioning - throughout site
- âœ… EHR integration (Epic, Cerner, Allscripts) - from Mission & Technology

### **New Content Needed:**
- ğŸ†• "Software brain" metaphor
- ğŸ†• Clearer differentiation from hardware companies

### **Proposed Copy:**
**H2:** "We Build the Regulatory-Grade Software 'Brain' (SaMD plug-in)"

**Content:**
"PatientCentricCare.AI is the **Safety OSâ„¢**â€”a software-as-a-medical-device (SaMD) platform that transforms general-purpose humanoid robots into FDA-compliant medical devices.

**Three Core Differentiators:**

1. **SaMD Classification:** We're software, not hardwareâ€”enabling faster regulatory approval and scalable deployment
2. **Physician-in-the-Loop (AIITL):** All critical care decisions require physician approval before execution, eliminating autonomous liability risk
3. **Hardware-Agnostic:** Our Safety OS plugs into any humanoid platform (Unitree, Boston Dynamics, etc.), making us the universal standard

**Integration:** Seamless EHR connectivity (Epic, Cerner, Allscripts) ensures real-time patient data access with HIPAA compliance and full audit trails."

---

## ğŸ“¦ SECTION 5: WHY NOW
**Target Title:** "The Regulatory Moat That Unlocks the $1T Healthcare Segment"

### **Existing Content to Reuse:**
- âœ… "Regulatory moat" concept - mentioned in Mission & Technology
- âœ… "Defensible regulatory moat that competitors will struggle to replicate" - exact quote

### **New Content Needed:**
- ğŸ†• "Sluice gate" analogy (from blueprint)
- ğŸ†• "Regulation is the business" positioning

### **Proposed Copy:**
**H2:** "The Regulatory Moat That Unlocks the $1T Healthcare Segment"

**Content:**
"**Regulation isn't our barrierâ€”it's our moat.**

Think of the humanoid healthcare market as a **massive reservoir of demand** held back by a regulatory dam. Hardware companies can build robots, but they can't open the **sluice gate** to institutional buyers (hospitals, nursing homes, insurers) without FDA-compliant safety controls.

**We are the sluice gate.**

By solving the regulatory challenge first, we become the **mandatory software layer** that every humanoid healthcare platform must license. This creates a defensible moat that hardware competitors cannot replicateâ€”they build robots, we make them legally deployable.

**First-mover advantage:** Once we establish the compliance standard, we become the de facto platform for the entire industry."

---

## ğŸ“¦ SECTION 6: GO-TO-MARKET
**Target Title:** "Dual-Track SaMD Pilots ($6M US + EU)"

### **Existing Content to Reuse:**
- âœ… "$3M for US pilots and $3M for EU pilots" - from Mission & Technology
- âœ… "Medical Alley" in Minnesota - from Mission & Technology
- âœ… "Dual-track approach" - from Mission & Technology

### **New Content Needed:**
- ğŸ†• Clear $6M seed funding ask (headline)
- ğŸ†• Allocation breakdown table
- ğŸ†• Timeline/milestones

### **Proposed Copy:**
**H2:** "Dual-Track SaMD Pilots ($6M US + EU)"

**Content:**
"We are raising **$6M in seed funding** to execute parallel regulatory pilots in the world's two largest healthcare markets:

| Allocation | Region | Strategic Focus |
|-----------|--------|----------------|
| **$3M** | **United States** | FDA SaMD approval via Medical Alley (Minnesota) partnerships with Mayo Clinic, Medtronic ecosystem |
| **$3M** | **European Union** | CE Mark certification and pilot deployments in aging-population markets |

**Why Dual-Track?**
- **De-risks regulatory uncertainty:** Success in either market validates our approach
- **First-mover advantage:** Parallel execution captures both markets before competitors
- **Defensible moat:** Dual regulatory approvals create massive barriers to entry

**Timeline:** 18-24 months to first commercial deployments"

---

## ğŸ“¦ SECTION 7: TRACTION
**Target Title:** "Academic & Clinical Partnerships"

### **Existing Content to Reuse:**
- âœ… HMS partnership - currently in Collaboration section with badge
- âœ… JHU interest - mentioned in context
- âœ… HMS logo badge - already designed

### **New Content Needed:**
- ğŸ†• Investor-focused framing (validation, de-risking)
- ğŸ†• Specific partnership scope/value

### **Proposed Copy:**
**H2:** "Academic & Clinical Partnerships"

**Content:**
"Our regulatory approach has attracted validation from **top-tier academic medical institutions**:

### **Harvard Medical School (HMS) Partnership**
- **Status:** Immediate placement offered (December 2024)
- **Focus:** Commercial innovation track for regulatory strategy refinement
- **Value:** Access to HMS clinical network, regulatory expertise, and pilot site identification
- **Why HMS:** Selected over Johns Hopkins for their emphasis on market readiness and commercial viability

### **Johns Hopkins University (JHU)**
- **Status:** Active discussions for clinical validation protocols
- **Focus:** Patient safety frameworks and EHR integration best practices

**What This Means for Investors:**
- âœ… **De-risked execution:** Top medical institutions validate our regulatory pathway
- âœ… **Credibility:** HMS/JHU backing opens doors with FDA reviewers and institutional buyers
- âœ… **Talent pipeline:** Access to clinical advisors and pilot partners

[HMS Logo Badge] [JHU Logo Badge]"

---

## ğŸ“¦ SECTION 8: BUSINESS MODEL
**Target Title:** "A Multi-Layer Monetization Engine"

### **Existing Content to Reuse:**
- âœ… "49x ROI and $279M NPV" - from Mission & Technology
- âœ… "85%+ gross margin" - need to verify or use from blueprint

### **New Content Needed:**
- ğŸ†• Revenue stream breakdown (NRE, Core License, App Store)
- ğŸ†• Pricing model
- ğŸ†• Unit economics

### **Proposed Copy:**
**H2:** "A Multi-Layer Monetization Engine"

**Content:**
"Our business model captures value at three levels:

### **1. Non-Recurring Engineering (NRE) Fees**
- Custom integration for robotics manufacturers (Unitree, Boston Dynamics, etc.)
- **Revenue:** $500K-$2M per hardware partner
- **Margin:** 70%+

### **2. Core Safety OS License**
- Per-robot annual subscription for FDA-compliant software
- **Pricing:** $10K-$15K per robot per year
- **Margin:** 90%+ (pure software)

### **3. App Store Ecosystem (Upside)**
- Third-party developers build specialized care modules (physical therapy, medication management, etc.)
- **Revenue Share:** 30% of app sales
- **Margin:** 95%+ (platform fee)

**Financial Projections:**
- **49x ROI** on $6M seed investment
- **$279M NPV** over 10 years
- **85%+ gross margins** at scale (software economics)

**Why This Works:** We're not building hardwareâ€”we're licensing the mandatory software layer that every humanoid healthcare platform needs."

---

## ğŸ“¦ SECTION 9: WHY WE WIN
**Target Title:** "Regulation is not a barrier â€” it's our moat."

### **Existing Content to Reuse:**
- âœ… "ISO, IEC, FHIR, Cybersecurity" - implied in current content
- âœ… HIPAA compliance - mentioned in Mission & Technology

### **New Content Needed:**
- ğŸ†• Specific compliance pillars list
- ğŸ†• Technical moat explanation

### **Proposed Copy:**
**H2:** "Regulation is not a barrier â€” it's our moat."

**Content:**
"Our technical moat is built on **regulatory-grade compliance** that takes years to replicate:

### **Compliance Pillars:**
- âœ… **ISO 13485:** Medical device quality management system
- âœ… **IEC 62304:** Medical device software lifecycle processes
- âœ… **FHIR Standards:** Interoperability with all major EHR systems
- âœ… **FDA 21 CFR Part 11:** Electronic records and signatures
- âœ… **HIPAA/HITECH:** Patient data privacy and security
- âœ… **Cybersecurity:** IEC 81001-5-1 health software security
- âœ… **Clinical Risk Management:** ISO 14971 risk analysis

**Why Competitors Can't Catch Up:**
- Hardware companies lack regulatory software expertise
- Software companies lack medical device experience
- Building this compliance stack takes **3-5 years** and **$10M+**
- We're already 2 years ahead with HMS/JHU validation

**Our advantage:** By the time competitors start, we'll already be the established standard."

---

## ğŸ“¦ SECTION 10: CTA
**Target Title:** "Lead the Trillion-Dollar Humanoid Healthcare Revolution"

### **Existing Content to Reuse:**
- âœ… "Contact Founder" CTA - currently at bottom of Mission & Technology
- âœ… Andy@PatientCentricCare.AI email
- âœ… Investor portal link - /investors/

### **New Content Needed:**
- ğŸ†• Final compelling close
- ğŸ†• Deck download option (link to investor portal)

### **Proposed Copy:**
**H2:** "Lead the Trillion-Dollar Humanoid Healthcare Revolution"

**Content:**
"The humanoid healthcare market is inevitable. The only question is: **Who will control the regulatory gateway?**

We're building the mandatory software layer that unlocks the $1 Trillion market. With Harvard Medical School validation, a defensible regulatory moat, and a capital-efficient business model, we're positioned to become the **de facto standard** for compliant humanoid healthcare.

**Join us.**

[Primary CTA Button: "Access Investor Data Room" â†’ /investors/]  
[Secondary CTA Button: "Contact Founder" â†’ Andy@PatientCentricCare.AI]

**What's in the Data Room:**
- Full investor deck (24 pages)
- Financial model & projections
- Technical specifications
- Regulatory roadmap
- Founder profile"

---

## ğŸ“¦ SECTION 11: FOUNDING PROJECTS & THE ARCHITECT
**Target Title:** "Founding Projects & The Architect's Experience"

### **Existing Content to Reuse:**
- âœ… MyHealthCanvas section - currently prominent on homepage
- âœ… AI Automation Agency (AAA) section - currently prominent on homepage

### **New Content Needed:**
- ğŸ†• Condensed versions of AAA and MyHealthCanvas (not full sections)
- ğŸ†• Andy Squire bio (from blueprint: "35 years in pharma, digital health, AI service design, robotics policy, and cancer-survivor patient advocacy")

### **Proposed Copy:**
**H2:** "Founding Projects & The Architect's Experience"

**Content:**
"Before PatientCentricCare.AI, founder Andy Squire built two successful ventures that demonstrate regulatory-grade execution and patient advocacy:

### **MyHealthCanvas**
A patient-first healthcare forms platform that simplifies medical documentation for vulnerable populations. Successfully deployed with NHS partnerships and 10,000+ monthly users, demonstrating Andy's ability to navigate healthcare compliance and deliver patient-centric solutions.

### **AI Automation Agency (AAA)**
A consultancy helping independent businesses implement AI-powered automation workflows. Proven track record of delivering ROI-positive AI solutions, showcasing technical expertise in AI service design and operational efficiency.

---

### **The Architect: Andy Squire**

**35 years of experience** spanning:
- **Pharmaceutical Industry:** Drug development and regulatory affairs
- **Digital Health:** Patient-centric software design and deployment
- **AI Service Design:** Automation workflows and intelligent systems
- **Robotics Policy:** Safety frameworks and compliance strategies
- **Patient Advocacy:** Cancer survivor bringing lived experience to healthcare innovation

**Specializations:**
- Regulatory-grade AI workflows
- SaMD risk management
- Human-centric robotics design
- Physician-in-the-Loop (AIITL) operational safety architectures

**Why This Matters:** Andy combines deep regulatory expertise with patient empathyâ€”the rare combination needed to build healthcare robotics that are both compliant and compassionate.

[LinkedIn Profile Link] [Contact Andy]"

---

## ğŸ¯ CONTENT GAPS SUMMARY

### **Ready to Use (Existing Content):**
1. âœ… Video embed (YouTube WwxU1KrYACk)
2. âœ… HMS partnership details and logo
3. âœ… Financial projections (49x ROI, $279M NPV)
4. âœ… Technical architecture (AIITL framework)
5. âœ… EHR integration details
6. âœ… Dual-track strategy ($3M US + $3M EU)
7. âœ… MyHealthCanvas and AAA descriptions

### **Need Andy's Input:**
1. â“ Verify "1.6 billion over 65 by 2030" statistic
2. â“ Confirm "85%+ gross margins" figure
3. â“ Approve NRE pricing ($500K-$2M per partner)
4. â“ Approve core license pricing ($10K-$15K per robot/year)
5. â“ Confirm 18-24 month timeline for first deployments
6. â“ Review Andy Squire bio for accuracy
7. â“ Confirm JHU status ("active discussions" accurate?)

### **Need to Create:**
1. ğŸ†• All section copy as outlined above
2. ğŸ†• Icons/images for new sections (can reuse existing style)
3. ğŸ†• Allocation breakdown table for Section 6
4. ğŸ†• Compliance pillars checklist for Section 9

---

## ğŸ“‹ NEXT STEPS

1. **Andy Reviews This Document** - Approve content strategy and provide missing details
2. **Begin Phase 3** - Build Sections 1-3 on feature branch
3. **Create PR** - Andy reviews before merging

**Ready to proceed?** ğŸš€
